Jan 09, 2024 / 11:00PM GMT
Christopher Thomas Schott - JPMorgan Chase & Co, Research Division - Senior Analyst
Good afternoon, everybody. I'm Chris Schott at JPMorgan, and it's my pleasure to be introducing Elanco today. From the company, we have Jeff Simmons, the company's President and CEO; and we're going to have the company's CFO, Todd Young, join us for Q&A.
So with that, I'm going to turn it over to Jeff.
Jeffrey N. Simmons - Elanco Animal Health Incorporated - President, CEO & Director
All right. Thanks, Chris, and thanks for all the great work you and JPMorgan are doing in animal health.
Before I begin, I'll quickly reference Slide 2, just on the disclaimer for forward-looking statements. And with that, I will get started.
Hey, 2024 marks a very important year for Elanco. It is our 70th year as an animal health company, the longest-standing brand in this durable, attractive industry. And we have a lot of great things that are happening this year as well that I'll get into and Todd will as well.
And listen, given animal health
Elanco Animal Health Inc at JPMorgan Healthcare Conference Transcript
Feb 10, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers